UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000034815
Receipt No. R000039704
Official scientific title of the study Response-oriented sequential therapy with four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma
Date of disclosure of the study information 2018/11/08
Last modified on 2018/11/08 12:19:52

No. Disposal Last modified on Item of update
1 Insert 2018/11/08 12:20:19


Contact us.